Literature DB >> 22914572

Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model.

Kristin Steigerwald1, Anna Titova, Caroline Malle, Elisabeth Kennerknecht, Clemens Jilek, Jörg Hausleiter, Jörg M Nährig, Karl-Ludwig Laugwitz, Michael Joner.   

Abstract

OBJECTIVES: Catheter-based renal artery denervation has been successfully introduced as alternative treatment for patients suffering from drug-resistant essential hypertension. However, the local morphological changes within the vessel wall accompanying this technique remain elusive and we sought to characterize these by utilizing the simplicity radiofrequency catheter approach.
METHODS: Following treatment of seven pigs, renal arteries were assigned to either the acute (n  =  6), subacute (10-day follow-up, n  =  6) or control (untreated, n  =  2) group. At follow-up blood analysis, final angiography and optical coherence tomography (OCT)-imaging of the treated arteries were performed and renal arteries and kidneys were processed for histopathology and immunohistochemistry.
RESULTS: Radiofrequency-derived energy application to the vessel wall induced transmural tissue coagulation and loss of endothelium resulting in local thrombus formation also detectable by OCT. At 10 days, the luminal surface was almost completely re-endothelialized. Mural wall damage was replaced by fibrotic tissue and the adventitial layer showed strong inflammatory infiltration including vasculogenesis. Remnant autonomic nerve fascicles within the lesion segments of the subacute group displayed enhanced vacuolic degeneration and an impaired neurofilament protein immunostaining pattern. Examination of the kidneys revealed no abnormalities and blood parameters remained within the physiological range.
CONCLUSION: Catheter-based application of radiofrequency energy resulted in circumscribed transmural injury within the arterial wall affecting autonomic nerve fascicles delayed to treatment. Acute loss of endothelialization resulted in thrombus formation leaving kidney perfusion apparently unimpaired.

Entities:  

Mesh:

Year:  2012        PMID: 22914572     DOI: 10.1097/HJH.0b013e32835821e5

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  28 in total

Review 1.  The biophysics of renal sympathetic denervation using radiofrequency energy.

Authors:  Hitesh C Patel; Paramdeep S Dhillon; Felix Mahfoud; Alistair C Lindsay; Carl Hayward; Sabine Ernst; Alexander R Lyon; Stuart D Rosen; Carlo di Mario
Journal:  Clin Res Cardiol       Date:  2014-05       Impact factor: 5.460

2.  Magnetic resonance guided renal denervation using active tracking: first in vivo experience in Swine.

Authors:  F Bönner; S Haberkorn; P Behm; B Schnackenburg; S Krüger; S Weiss; C Meyer; M Kelm; M Neizel-Wittke
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-27       Impact factor: 2.357

3.  [Renal denervation. Current developments].

Authors:  A Saleh
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

Review 4.  Renal denervation: intractable hypertension and beyond.

Authors:  Wassawon Ariyanon; Huijuan Mao; Zelal Adýbelli; Silvia Romano; Mariapia Rodighiero; Bernhard Reimers; Luigi La Vecchia; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-01-15       Impact factor: 2.041

5.  Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension.

Authors:  Abraham R Tzafriri; John H Keating; Peter M Markham; Anna-Maria Spognardi; James R L Stanley; Gee Wong; Brett G Zani; Debby Highsmith; Patrick O'Fallon; Kristine Fuimaono; Felix Mahfoud; Elazer R Edelman
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

Review 6.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

7.  [Heart and kidneys. Renal denervation as therapy for hypertension].

Authors:  F Mahfoud; D Linz; M Böhm
Journal:  Herz       Date:  2013-02       Impact factor: 1.443

8.  Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

Authors:  Mark R de Jong; Annemiek F Hoogerwaard; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Isabelle C Van Gelder; Harry J G M Crijns; Ignacio Fernández Lozano; Jorge E Toquero Ramos; F Javier Alzueta; Borja Ibañez; José M Rubio; Fernando Arribas; José M Porres Aracama; Josep Brugada; Lluís Mont; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-02-27       Impact factor: 5.460

9.  Long-term follow-up of renal arteries after radio-frequency catheter-based denervation using optical coherence tomography and angiography.

Authors:  Tomasz Roleder; Mariusz Skowerski; Andrzej Wiecek; Marcin Adamczak; Beata Czerwienska; Wojciech Wanha; Tomasz Jadczyk; Lukasz Partyka; Grzegorz Smolka; Wacław Kuczmik; Andrzej Ochała; Dariusz Dudek; Michał Tendera; Zbigniew Gasior; Wojciech Wojakowski
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-16       Impact factor: 2.357

10.  Renal denervation beyond the bifurcation: The effect of distal ablation placement on safety and blood pressure.

Authors:  Martine M A Beeftink; Wilko Spiering; Mark R De Jong; Pieter A Doevendans; Peter J Blankestijn; Arif Elvan; Jan-Evert Heeg; Michiel L Bots; Michiel Voskuil
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.